세계의 프로테아제 시장 : 예측(2025-2030년)

The protease market is expected to grow at a CAGR of 5.91%, reaching a market size of US$3.663 billion in 2030 from US$2.749 billion in 2025.

Proteases form a large class of enzymes used in trade, especially in food, detergent, and pharmaceutical applications. They include amidases, peptidases, and proteinases. Among important industrial enzymes, proteases have a very wide range of applications in chemical and biological processes responsible for the breakdown of peptide ties in proteins. One of the interesting features of proteases is their efficiency in generating natural products, doing so in milder reaction conditions and exhibiting stereospecificity, specificity, and biodegradability among their properties. Innovative reaction-time-reduction techniques have been invented by firms for increased yield enhancement. Many fast-moving consumer goods (FMCG) include proteases, adding to their relevance. The most significant aspect of increasing the market size for proteases is that they have many applications in different sectors. The toxicity and pathogenicity make them even greener ingredients, expanding the market.

Protease Market Drivers

• Increasing biotechnology and research initiatives are contributing to the protease market expansion

Owing to their potentiality as popular tools for protein analysis, DNA research, and recombinant DNA (rDNA) technology, the market will likely be continually fueled by biotechnology and research projects. Proteases facilitate the study of protein structure and function by allowing for precise protein cleavage. They are thus important to biopharmaceuticals' production, purification, and drug discovery processes. They can also be found in diagnostic procedures and enzyme replacement therapies. The fast advancements in genetic engineering and biotechnology will also challenge the need for novel specialty proteases with specific roles.

Geographical Outlook of the Protease Market:

• North America is witnessing exponential growth during the forecast period.

In North America, proteases are used within the complex and sophisticated sectors of biotechnology and pharmaceuticals for application in therapeutics, protein engineering, and drug development. The US FDA provides a regulatory environment that helps develop and commercialize protease-based products and the food and pharmaceutical industries; regulation assists in the market adoption of proteases by ensuring they are effective and safe. Increasing demand for functional foods and health supplements has resulted in the high usage of the protease enzyme in such products. Therefore, an increasing demand for nutraceuticals is aroused as more people understand proteases' health benefits.

Reasons for buying this report:-

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data & forecasts from 2022 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The protease market is segmented and analyzed as follows:

By Source

• Plants
• Animals
• Microbes

By Form

• Powder
• Liquid
• Others

By Application

• Animal feed industry
• Food & Beverage industry
• Others

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• Italy
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Taiwan
• Thailand
• Indonesia
• Others

TABLE OF CONTENTS

1. INTRODUCTION

• 1.1. Market Overview
• 1.2. Market Definition
• 1.3. Scope of the Study
• 1.4. Market Segmentation
• 1.5. Currency
• 1.6. Assumptions
• 1.7. Base and Forecast Years Timeline
• 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

• 2.1. Research Design
• 2.2. Research Processes

3. EXECUTIVE SUMMARY

• 3.1. Key Findings
• 3.2. CXO Perspective

4. MARKET DYNAMICS

• 4.1. Market Drivers
• 4.2. Market Restraints
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers
  • 4.3.2. Bargaining Power of Buyers
  • 4.3.3. Threat of New Entrants
  • 4.3.4. Threat of Substitutes
  • 4.3.5. Competitive Rivalry in the Industry
• 4.4. Industry Value Chain Analysis
• 4.5. Analyst View

5. PROTEASE MARKET BY SOURCE

• 5.1. Introduction
• 5.2. Plants
• 5.3. Animals
• 5.4. Microbes

6. PROTEASE MARKET BY FORM

• 6.1. Introduction
• 6.2. Powder
• 6.3. Liquid
• 6.4. Others

7. PROTEASE MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Animal feed industry
• 7.3. Food & Beverage industry
• 7.4. Others

8. PROTEASE MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Source
  • 8.2.2. By Form
  • 8.2.3. By Application
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Source
  • 8.3.2. By Form
  • 8.3.3. By Application
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Source
  • 8.4.2. By Form
  • 8.4.3. By Application
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. Italy
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Source
  • 8.5.2. By Form
  • 8.5.3. By Application
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. Israel
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Source
  • 8.6.2. By Form
  • 8.6.3. By Application
  • 8.6.4. By Country
    • 8.6.4.1. Japan
    • 8.6.4.2. China
    • 8.6.4.3. India
    • 8.6.4.4. Australia
    • 8.6.4.5. South Korea
    • 8.6.4.6. Taiwan
    • 8.6.4.7. Thailand
    • 8.6.4.8. Indonesia
    • 8.6.4.9. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. E.I. Du Pont De Nemours and Company
• 10.2. Novozymes A/S
• 10.3. Advanced Enzyme Technologies
• 10.4. DSM
• 10.5. Associated British Food
• 10.6. Neova Technologies Inc
• 10.7. Thermo Fisher Scientific
• 10.8. Kemin Industries
• 10.9. Promega Corporation
• 10.10. Merck
• 10.11. Novus International Inc.
• 10.12. International Flavors & Fragrances Inc.
• 10.13. Biocatalyst Ltd.
• 10.14. Novonesis Group.
• 10.15. Bioseutica BV.